M
M. Ali
Publications - 7
Citations - 124
M. Ali is an academic researcher. The author has contributed to research in topics: Cardiotoxicity & Trastuzumab. The author has an hindex of 2, co-authored 7 publications receiving 103 citations.
Papers
More filters
Journal ArticleDOI
Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy
Paolo Andrea Zucali,Tommaso De Pas,Giovannella Palmieri,Adolfo Favaretto,Antonio Chella,Marcello Tiseo,Michele Caruso,Matteo Simonelli,Matteo Perrino,Fabio De Vincenzo,Francesca Toffalorio,Vincenzo Damiano,Giulia Pasello,Erika Garbella,M. Ali,Fabio Conforti,Margaret Ottaviano,Angela Cioffi,Sabino De Placido,Laura Giordano,Monica Bertossi,Annarita Destro,Luca Di Tommaso,Armando Santoro +23 more
TL;DR: Everolimus may induce durable disease control in a high percentage of patients with T or TC, albeit with a potential high risk of fatal pneumonitis, as evaluated in a single-arm, single-stage, open-label, multicenter, phase II trial.
Journal ArticleDOI
Appropriate management of cutaneous adverse events maximizes compliance with sorafenib treatment: a single-center experience
Giuseppa Scandurra,Rosa Anna Aiello,M. Ali,E. Taibi,Maria Vita Sanò,Francesco Maurizio Todaro,Rosaria La Rocca,Paolo Licciardello,Michele Caruso +8 more
TL;DR: The treatment approach seemed to reduce the incidence and/or severity of AEs, keeping patients in treatment, which is essential for good treatment outcomes.
Journal ArticleDOI
Neoadjuvant trastuzumab and sequential chemotherapy with cisplatin, vinorelbine, and docetaxel for stage II-III breast cancer patients: Final results of a single institution phase II study.
Guido Carillio,Rosa Anna Aiello,Maurizio Chiarenza,M. Ali,Antonella Mazzola,Rosanna Di Marco,E. Taibi,G. Fallica,Tiziana Casella,Alessandra Zacchia,Gaetano Castiglione,Francesco Caruso,Michele Caruso +12 more
TL;DR: A phase II study of neoadjuvant trastuzumab and sequential chemotherapy was started in the late 2007 at Humanitas CCO and enrolled 42 patients with stage II-III HER2-positive breast cancer.
Journal ArticleDOI
Association of weekly gemcitabine to conformal radiotherapy as organ-sparing strategy in locally advanced or relapsed bladder cancer
Guido Carillio,M. Ali,A. Mazzola,S. Bagnato,A. Todaro,A. D’Agostino,A. Girlando,Rosa Anna Aiello,G. Fallica,Maurizio Chiarenza,Michele Caruso +10 more
TL;DR: In this paper, the authors considered the only curative option for locally advanced or relapsed bladder cancer, but the uncertain prognosis of disease and the poor quality of life du...
Journal ArticleDOI
Use of trastuzumab associated with cisplatin and vinorelbine followed by docetaxel as a neoadjuvant regimen for patients with HER2-positive breast cancer.
Guido Carillio,Rosa Anna Aiello,A. Mazzola,M. Ali,Giuseppa Scandurra,E. Taibi,Maurizio Chiarenza,G. Fallica,Francesco Caruso,Michele Caruso,Humanitas Centro Catanese di Oncologia +10 more
TL;DR: Peg-filgrastim was given to prevent neutropenia and to potentiate the proposed mechanisms of action of trastuzumab, such as activatio...